abstract |
The present invention relates, at least in part, to new 7-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline-sensitive conditions, such as bacterial infections and neoplasms, as well as other known applications of minocycline and tetracycline compounds, mainly as tetracycline outflow blockers and modulating gene expression. was published 2002.04.04. |